?> Contact us Follow Us
Biosimilars Forum
  • About Us
    • Members
    • Executive Director
  • Why Biosimilars
  • Biosimilars 101
  • Policies
    • Biosimilars are a Free-Market Solution
    • The Biosimilar Access and Affordability Act
  • News
  • Resources

Biosimilars Forum

Get more out of your business.
Reach it with Microsoft Dynamics 365 Business Central.
News
February 26, 2019 Biosimilars Forum
Removing 340B Pass-Through Would be Detrimental to US Healthcare Savings
News
February 26, 2019 Biosimilars Forum
The Biosimilars Forum Urges Senate Finance Committee to Seek Meaningful Biosimilars Reform
News
February 12, 2019 Biosimilars Forum
The Biosimilars Forum Objects to Consolidate Billing of Biosimilars
News
February 1, 2019 Biosimilars Forum
The Biosimilar Forum Recognizes Leah Christl’s Departure from FDA
News
January 31, 2019 Biosimilars Forum
The Biosimilars Forum Applauds HHS Proposal to Target Costly Rebates Structure Blocking Patients from Biosimilars and Savings
News
December 13, 2018 Biosimilars Forum
The Biosimilars Forum Commends FDA for Commitment to Increase Patient Access to Biosimilars
News
December 4, 2018 Biosimilars Forum
Biosimilars Forum Statement on Citizen Petition to the Food and Drug Administration
News
December 3, 2018 Biosimilars Forum
Biosimilars Forum Announces Launch of Biosimilars Roundtable
News
October 10, 2018 Biosimilars Forum
New White Paper Finds Biosimilars Could Drive Greater Value Beyond Price for Healthcare System
News
August 9, 2018 Biosimilars Forum
Biosimilars Forum Statement on CMS Announcement Regarding Medicare Advantage
  • Prev page
  • 01
  • 02
  • 03
  • 04
  • 05
  • Next page

  • Biosimilars 101
  • Policies
  • Stay Connected
Biosimilars Forum
© 2026 Biosimilars Forum. All rights reserved.
  • Terms of Use
  • |
  • Privacy Policy
  • |
  • Contact Us